Skip to Content

First Trust NYSE Arca Biotech ETF FBT

Medalist Rating as of | See First Trust Investment Hub

Morningstar’s Analysis FBT

Will FBT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit First Trust NYSE Arca Biotech ETF to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBT

  • Current Portfolio Date
  • Equity Holdings 30
  • Bond Holdings 0
  • Other Holdings 1
  • % Assets in Top 10 Holdings 38.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
4.14
52,430,500
Healthcare
4.10
51,915,596
Healthcare
4.08
51,587,050
Healthcare
4.04
51,131,832
Healthcare
3.95
49,996,184
Healthcare
3.92
49,679,030
Healthcare
3.78
47,846,817
Healthcare
3.55
44,910,888
Healthcare
3.47
43,914,949
Healthcare